InvestorsHub Logo
Followers 10
Posts 1039
Boards Moderated 0
Alias Born 07/08/2006

Re: dr_lowenstein post# 295802

Thursday, 07/26/2018 7:19:12 PM

Thursday, July 26, 2018 7:19:12 PM

Post# of 401489
But, but, but none of the investors/shareholders here said that isradipine was the only CCB that could be used in a PD trial but there are studies now being conducted using isradipine exclusively in their efficacy trials.

but but but I was told that only isradipine could have this effect because it was the only ccb that crossed the blood brain barrier. Course, I blew that one out of the water as well.



http://pdcenter.neurology.ucsf.edu/research/learn-about-closed-studies/steady-pd3-efficacy-isradipine-early-pd-no-longer-recruiting

https://parkinsonsdisease.net/research/isradipine/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News